Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021

SELL
$54.4 - $73.42 $3,916 - $5,286
-72 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$61.66 - $70.16 $2,959 - $3,367
48 Added 200.0%
72 $4,000
Q4 2018

Feb 14, 2019

BUY
$78.25 - $107.92 $1,878 - $2,590
24 New
24 $2,000

Others Institutions Holding TARO

About TARO PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TARO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 37,584,600
  • Description
  • Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...
More about TARO
Track This Portfolio

Track Glenmede Trust CO Na Portfolio

Follow Glenmede Trust CO Na and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

News

Stay updated on Glenmede Trust CO Na with notifications on news.